Quintiles has signed a two-year agreement with the Vietnam Ministry of Health’s Administration of Science, Technology and Training (ASTT), aimed at improving the country’s clinical-research environment.
Together, ASTT and Quintiles will set up a working group to address various topics relating to clinical research in Vietnam, including enhanced processes for trial management; development of streamlined processes to improve trial efficiency and quality; and training for investigators and ethics committees.
The US-based provider of biopharmaceutical development and commercial outsourcing services has been working with the Ministry of Health to provide investigator training and site development in Vietnam since it first established a local presence in 2005.
“This agreement deepens our commitment to developing medicines here to fight tropical and infection diseases and other conditions that afflict populations in Vietnam and Southeast Asia,” noted Dr Ross Horsburgh, who leads Quintiles' operations in Southeast Asia, Taiwan, South Korea, Australia and New Zealand.
ASTT director Professor Dr Nguyen Cong Khan said Quintiles “knows how to conduct clinical research to global standards and its experts understand Asia and Vietnam”.
By sharing its knowledge and insights, the company can “help us develop and execute a long-term plan for improving the quality, scope and breadth of clinical research in Vietnam”, Khan added.
Quintiles Vietnam LLC has offices in Ho Chi Minh City and Hanoi.